Back to BMRN Stock Lookup

BMRN Related Analyst Ratings

Mar 20, 2013 01:30 PM BioMarin's BMN-701 has 60% Probability of Success, Says Analyst

Jan 22, 2013 08:20 AM Stifel Nicolaus Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy

Jan 2, 2013 05:45 PM Janney Montgomery Scott Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy

Nov 6, 2012 07:30 AM Brean Capital Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold

Nov 5, 2012 03:02 PM Leerink Swann Sees Another 30% Upside in BioMarin (BMRN)

Nov 5, 2012 02:12 PM Baird Expects Q413 Launch of BioMarin's (BMRN) GALNS

Oct 3, 2012 07:46 AM Jefferies Says GALNS to drive 30% Upside in BioMarin (BMRN)

Sep 5, 2012 08:56 AM Canaccord Genuity Maintains a 'Buy' on BioMarin Pharmaceutical (BMRN); Framing the GALNS Case

Aug 27, 2012 07:17 AM Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Risk/Reward Into Phase 3 GALNS

Aug 24, 2012 12:23 PM UPDATE: Barclays Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight; Three Shots on Goal

Aug 22, 2012 09:34 AM Baird Reiterates an 'Outperform' on BioMarin Pharmaceutical (BMRN); GALNS on the Clock

Aug 7, 2012 07:52 AM Lazard Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy

Aug 2, 2012 10:19 AM Canaccord Genuity on BioMarin (BMRN): November Data + M&A Speculation = Top Pick

Aug 2, 2012 07:25 AM Baird Reiterates an 'Outperform' on BioMarin Pharmaceutical (BMRN); Clean Commercial Platform/Robust Pipeline

Jul 13, 2012 11:21 AM Piper Jaffray Boosts Target on BioMarin (BMRN) to $52 After Addition of BMN-701 to Model

Jun 29, 2012 07:17 AM ThinkEquity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy

Jun 12, 2012 03:49 PM Piper Jaffray Says BioMarin (BMRN) Could Be Taken Out for $52-$70/Share

Apr 27, 2012 11:35 AM Canaccord Genuity Reiterates a 'Buy' on BioMarin Pharmaceutical (BMRN); Watching The Pipeline

Apr 20, 2012 10:05 AM Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect

Apr 12, 2012 11:07 AM UPDATE - UBS Initiates Coverage on BioMarin (BMRN) with a Buy; Accumulate on Pullback

Apr 12, 2012 08:18 AM UBS Starts BMRN, RDEA, ARIA at Buy, ITMN, ACHN, HGSI, IRWD at Neutral

Mar 26, 2012 08:58 AM Canaccord Genuity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy

Mar 19, 2012 07:21 AM Brean Murray Carret & Co. Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy; Increased Confidence in GALNS Phase 3 Trial

Feb 22, 2012 07:49 AM Citi Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy

Feb 17, 2012 07:11 AM Baird Reiterates an 'Outperform' BioMarin Pharmaceutical (BMRN); Misses, Guides Lower, but Pipeline Events Remain Key

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Oct 17, 2011 08:52 AM Jefferies Raises Numbers On BioMarin (BMRN) After Update from ICHG/ASHG

Sep 28, 2011 07:06 AM Deutsche Bank Upgrades BioMarin Pharmaceutical (BMRN) to Buy; Model Ready to Leverage Promising Pipeline

Sep 23, 2011 07:47 AM Baird Maintains an 'Outperform' on BioMarin Pharmaceutical (BMRN); Valuation Still Attractive, Remains a Core Holding

Sep 16, 2011 07:59 AM RBC Capital Starts BioMarin Pharmaceutical (BMRN) at Outperform

Aug 10, 2011 07:43 AM Piper Jaffray Upgrades BioMarin Pharmaceutical (BMRN) to Overweight

Jul 29, 2011 11:50 AM Jefferies Lilfts Price Target on BioMarin (BMRN)

Apr 29, 2011 11:42 AM Collins Stewart Raises Price Target on BioMarin Pharmaceutical (BMRN) Following Solid Q1 Results and Q2 Guidance

Feb 18, 2011 10:00 AM Jefferies Cuts Estimate & Raises Price Target on BioMarin Pharmaceutical (BMRN), Maintains Buy Rating

Feb 18, 2011 08:42 AM Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Like Early Pipeline but Risk/Reward not Favorable

Feb 18, 2011 08:31 AM Deutsche Bank Cuts BioMarin Pharma (BMRN) to Hold Following Q4 Earnings

Dec 2, 2010 11:54 AM UPDATE - UBS Downgrades BioMarin (BMRN) to Neutral; Valuation Call

Dec 2, 2010 07:42 AM UBS Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Neutral

Nov 1, 2010 09:18 AM Morgan Joseph Downgrades BioMarin Pharmaceutical (BMRN) to Hold; Take Profits on Recent Gains

Oct 18, 2010 01:30 PM Gleacher & Co Initiates Coverage on BioMarin Pharmaceutical (BMRN) with a Neutral

Oct 18, 2010 07:54 AM Deutsche Bank Initiates Coverage on BioMarin Pharmaceuticals (BMRN) with a Buy; Two Shots on Goal in 2011 for Additional Value

Sep 1, 2010 08:29 AM Morgan Joseph Upgrades BioMarin (BMRN) to Buy, A Genzyme Deal Could Highlight Attractiveness

Aug 11, 2010 09:37 AM Citi Moves Myriad Genetics (MYGN) to 'Hold/High Risk'; Over-Reliance on BRACAnalysis

Jul 13, 2010 09:58 AM Citi Maintains a 'Hold' Rating on Auxilium Pharmaceuticals (AUXL); Prefers BMRN

Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)

Jul 7, 2010 12:42 PM Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)

Apr 30, 2010 07:10 AM Piper Jaffray Maintains a 'Neutral' on BioMarin (BMRN); Increasing PT Based On MPS IV Patient Pool For GALNS

Mar 17, 2010 10:21 AM UBS Maintains a 'Buy' Rating on BioMarin (BMRN); Raises PT & Estimates

Mar 12, 2010 08:09 AM Piper Jaffray Initiates Coverage on BioMarin (BMRN) with a Neutral; Current Valuation Assumes Success of GALNS

Feb 9, 2010 07:26 AM Roth Capital Upgrades BioMarin Pharmaceutical (BMRN) to Buy

Back to BMRN Stock Lookup